How much revenue does Kabra Drugs make?

Kabra Drugs reported 0 INR in revenue for fiscal year 2025. In Q3 2026 revenue was 304.20 million INR.

What companies are similar to Kabra Drugs?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Mercury Laboratories Limited (MERCURYLAB.BO), Shelter Pharma Limited (SHELTER.BO), Parmax Pharma Limited (PARMAX.BO), Vista Pharmaceuticals Limited (VISTAPH.BO).

Kabra Drugs Limited (KABRADG.BO) Stock

About Kabra Drugs Limited

Aanjaay Industries Limited engages in the manufacture and trade of pharmaceutical products. Its product portfolio includes cardiovascular, anti-infective, oncology, gastroenterologic, hormonal, and miscellaneous drugs; critical care injectibles, pre-filled syringes, and active pharmaceutical ingredients. The company was formerly known as Kabra Drugs Limited and changed its name to Aanjaay Industri...

At a glance

Kabra Drugs reported revenue of 0 INR for fiscal year 2025, and net income of -10.86 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 304.20 million INR.

Figures from company filings; latest fiscal year ended March 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.